Remote Simultaneous Medical Interpreting and Medical Outcomes

DIabetes Clinical Trial

— RSMI  

Official title:

Remote Simultaneous Medical Interpretation: Medical Outcomes

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00522327
• Other study ID #: Calendow/CMWF
• Status: Completed
• Phase: N/A
• First received: August 27, 2007
• Last updated: July 2, 2015
• Start date: November 2004
• Est. completion date: October 2006

Study information

• Verified date: July 2015
• Source: New York University School of Medicine
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

All new patients to the general medicine clinic who were not primarily English speaking were randomized, after consenting, to receieve either remote simultaneous medical interpreting or usual and customary interpreting services. Patient charts were followed for one year after enrollment to assess medical outcomes, including patient satisfaction, diabetes management, lipid management, depression screening and management, vaccine administration.

All Spanish-speaking ER patients were similarly enrolled. They were followed for one ER visit and their knowledge of exit instructions was assessed, as well as their satisfaction with care.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1200
• Est. completion date: October 2006
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 85 Years

Eligibility

Inclusion Criteria:

• Limited English-speaking

• English-speaking

• New patient in medicine clinic

Study Design

Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label

Related Conditions & MeSH terms

• DIabetes

Intervention

Other:
• remote simultaneous medical interpreting
remote simultaneous medical interpretation
• usual and customary
usual and customary interpreting
• ENglish speaking
English speakers

Locations

Country	Name	City	State
n/a

Sponsors (3)

Lead Sponsor	Collaborator
New York University School of Medicine	The California Endowment, The Commonwealth Fund

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Adherence with care		one year
Secondary	care parameters		one year